Episodio – Inhibidores de PCSK9: por qué aumentan los receptores LDL | USMLE Step 1 episode artwork

EPISODE · Jan 14, 2026 · 4 MIN

Episodio – Inhibidores de PCSK9: por qué aumentan los receptores LDL | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Paciente con enfermedad coronaria prematura y LDL persistentemente elevado pese a manejo estándar inicia evolocumab. En este episodio explicamos, paso a paso y sin agregar información externa, el mecanismo de acción de los inhibidores de PCSK9 y el efecto inmediato esperado sobre el receptor de LDL en el hepatocito.#USMLEDreamers #Cardiología #Lípidos #PCSK9 #Farmacología #USMLEStep1

Episode metadata supplied by the publisher feed · Published Jan 14, 2026

Embed this episode

NOW PLAYING

Episodio – Inhibidores de PCSK9: por qué aumentan los receptores LDL | USMLE Step 1

0:00 4:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 4 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on January 14, 2026.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!